Company
United StatesCTI Biopharma Corp, Seattle, WA – FDA Inspections
Inspection records and compliance data for CTI Biopharma Corp in Seattle, Washington. 2 FDA inspections on record, last inspected May 25, 2021.
Company Profile
This profile covers CTI Biopharma Corp based in Seattle, Washington, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected November 18, 2009. Last inspected May 25, 2021.
Most cited issue areas
- Notification of FDA of termination of investigator1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 25, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1143134 |
| November 18, 2009 | VAI | Human Drugs · Bioresearch Monitoring | 628277 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
CTI Biopharma Corp
FEI Number
1000135672
Address
3101 Western Ave Ste 800, Seattle, Washington 98121, United States
Country
United States
ID: 889b5609-a75d-43f9-8789-a4930350527b